menu search

sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

sensei biotherapeutics appoints stephanie krebs, ms, mba, as chief business officer

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stag...

November 1, 2023, 11:30 am

sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage...

October 25, 2023, 9:05 am

Adobe: buy the bullish momentum (technical analysis)

Adobe's strategic move into AI for content creation has strengthened bullish sentiment surrounding the stock, with the introduction of AI-driven tools...

June 11, 2023, 11:15 am

Adobe (adbe) boosts experience cloud with new innovations

Adobe (ADBE) introduces the latest generative AI innovations in Adobe sensei GenAI to aid businesses in...

June 9, 2023, 11:27 am

sensei biotherapeutics to participate in jefferies global healthcare conference

BOSTON, May 31, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage...

May 31, 2023, 11:30 am

sensei biotherapeutics presents new preclinical data on sns-103 targeting entpdase1 (cd39) at the american association for cancer research (aacr) annual meeting 2023

BOSTON, April 18, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-onco...

April 18, 2023, 8:05 pm

Adobe launches generative ai tools aimed at marketers

Coinciding with the launch of its Firefly family of generative AI models, Adobe today unveiled Adobe sensei...

March 21, 2023, 9:00 am

sensei biotherapeutics to present new preclinical data for sns-101, a conditionally active vista-blocking antibody, at the keystone symposia on next generation antibody therapeutics

BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncolo...

February 14, 2023, 7:30 am


Search within

Pages Search Results: